CMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
For the first time, Medicare will negotiate prices directly with drug companies on behalf of people with Medicare, improving affordability for some of the costliest prescription drugs
Press ReleasesCMS Office of the Actuary Releases 2022-2031 National Health Expenditure Projections
Average annual growth in national health spending over the next decade projected to be 5.4%
Press ReleasesInflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
HHS announces savings for some people with Medicare on 43 Part B prescription drugs
Press ReleasesCMS announces plan to ensure availability of new Alzheimer’s drugs
Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval
Press ReleasesBiden-Harris Administration Announces Proposal to Advance Prescription Drug Transparency in Medicaid
New HHS proposal would shed light on cost of prescription drugs and save states and federal government money in Medicaid
Press ReleasesMedicaid Drug Price Verification Survey and Pharmacy Benefit Manager Drug Price Transparency
CMS is proposing to verify certain drug prices reported by manufacturers through an annual Medicaid
Fact SheetsMisclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program Notice for Proposed Rulemaking (CMS-2434-P)
The Centers for Medicare & Medicaid Services’ (CMS’) proposed rule seeks to advance policies to
Fact SheetsIncreased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose
Study findings support the continuation of providing telehealth services for opioid use disorder and its related care
Press ReleasesInflation Reduction Act Tamps Down on Prescription Drug Price Increases Above Inflation
Updated March 30, 2023
New Medicare Prescription Drug Inflation Rebate Program protects people with
Press ReleasesHHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026
For the first time, Medicare will be able to negotiate prices directly with drug companies, ensuring lower prices on some of the costliest prescription drugs
Press Releases